Cargando…
Interleukin-27 ameliorates allergic asthma by alleviating the lung Th2 inflammatory environment
Interleukin (IL)-27 can inhibit the differentiation of Th2 cells and plays a role in the development of asthma. However, whether the therapeutic administration of IL-27 in a mouse model of asthma can inhibit allergic responses remains a matter of debate. Additionally, the mechanisms through which IL...
Autores principales: | Lu, Jiameng, Ji, Xiaoqing, Wang, Lixia, Sun, Fei, Huang, Chuanjun, Peng, Haiying, Jiang, Yunxiu, Guo, Zihan, Liu, Xinyi, Ji, Yanbo, Lu, Degan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106376/ https://www.ncbi.nlm.nih.gov/pubmed/35514302 http://dx.doi.org/10.3892/ijmm.2022.5142 |
Ejemplares similares
-
IL-27 suppresses airway inflammation, hyperresponsiveness and remodeling via the STAT1 and STAT3 pathways in mice with allergic asthma
por: Lu, Degan, et al.
Publicado: (2020) -
Machine Learning-Based Radiomics for Prediction of Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma
por: Lu, Jiameng, et al.
Publicado: (2022) -
Semaphorin 7a aggravates TGF-β1-induced airway EMT through the FAK/ERK1/2 signaling pathway in asthma
por: Peng, Haiying, et al.
Publicado: (2023) -
Pleural involvements in pulmonary sarcoidosis: A case report and review of the literature
por: Ji, Xiaoqing, et al.
Publicado: (2022) -
Metformin alleviates allergic airway inflammation and increases Treg cells in obese asthma
por: Guo, Yimin, et al.
Publicado: (2021)